Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)

Clinical trial NCT04303884 · UNKNOWN

Trial details

NCT number: NCT04303884
Sponsor: CHA University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gestational Trophoblastic Neoplasia

Start date: 2020-06-01
Primary completion: 2022-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.